Thursday, March 9, 2017 Presentations
- Systematic Development of Prostate Cancer Liquid Biopsies: Proteomics and Proteogenomics of Post-DRE Urines and Cancer Tissues
- High-density Antibody Arrays as Proteomic, Glycomic and Autoantibody Discovery Tools
- Integrating HuProt Array PTM Activity Profiling with MS Proteomic Analysis for Biomarker/Target Discovery
- Methylome Analysis using Methylation Arrays: Application to Gastrointestinal Cancers
- Early Detection of NSCLC: PBMC to PAXgene/Microarrays to Nanostring
- Targeted DNA and RNA Sequencing to Understand Cancer Development and Detection